The nation of Zimbabwe has rejected a significant American health deal valued at $367m (272 million pounds) over five years because of Washington's demand for confidential biological samples.
The decision was revealed after a internal memorandum dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "skewed".
An official representative later explained that the US was requesting health data for scientific study and commercial purposes while refused to guarantee the benefits from any future treatments.
"We will now turn to the challenging and unfortunate process of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had donated over $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for further negotiations to find a deal agreeable to both sides so the nation's critical HIV treatment initiative can continue.
Broader Context
Zimbabwe's decision follows a comparable situation in Kenya, where a high court blocked a similar deal with the US following legal challenges were filed about the security of citizens' medical information.
After resuming office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump argued its spending was "inefficient" and his government was pursuing government-to-government agreements to boost transparency and accountability.
As per statements, Sixteen African countries have so far agreed to similar health pacts, constituting over $18.3bn in new funding.
Details of the Rejected Agreement
The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this partnership would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its biological resources and data for a long time, with no equivalent assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.
"Put simply, our nation would provide the raw materials for medical research without any certainty that the final treatments would be available to our population should a new disease outbreak arise."
National Interest and International Frameworks
He also noted that the American exit from the global health body and its push of bilateral health agreements were disrupting systems already set up via the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system created to manage potential pandemics.
"This mechanism is intended to ensure that when a nation contributes its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
These objections over the US deal "should not be misconstrued as opposition to America," he added.
"We encourage continued discussions with our US partners on how future co-operation might be designed in a manner that honours the sovereignty and dignity of each country."
Health Experts Reaction
Medical experts said it acknowledged the official position, but suggested that talks must proceed considering a large portion of the country's Aids initiatives relied on international support.
"Where technical issues exist, including those involving information security or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," the group added.
The halted deal underscores the continuing tensions between receiving much-needed foreign assistance and protecting a country's data in an increasingly interconnected world.